These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 825477)

  • 1. Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease.
    Pross HF; Baines MG
    Int J Cancer; 1976 Nov; 18(5):593-604. PubMed ID: 825477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.
    Pross HF; Jondal M
    Clin Exp Immunol; 1975 Aug; 21(2):226-35. PubMed ID: 810282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations.
    Jondal M; Pross H
    Int J Cancer; 1975 Apr; 15(4):596-605. PubMed ID: 806545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human spontaneous lymphocyte-mediated cytotoxicity (SLMC) against malignant and normal tissue-derived target cell lines tested in autologous and allogeneic combinations by the microcytotoxicity assay.
    Vilien M; Troye-Blomberg M; Perlmann P; Wolf H; Rasmussen F
    Cancer Immunol Immunother; 1983; 14(3):137-44. PubMed ID: 6573229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte-dose response relationship in spontaneous lymphocyte mediated cytotoxicity (SLMC) measured by microcytotoxicity assay.
    Vilien M; Schultz K; Wolf H; Rasmussen F
    Acta Pathol Microbiol Immunol Scand C; 1982 Dec; 90(6):285-91. PubMed ID: 7170957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.
    West WH; Cannon GB; Kay HD; Bonnard GD; Herberman RB
    J Immunol; 1977 Jan; 118(1):355-61. PubMed ID: 299761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity among human lymphocyte effector cells mediating spontaneous lymphocyte-mediated cytotoxicity.
    Vessella RL; Gormus BJ; Lange PH; Kaplan ME
    Int J Cancer; 1978 May; 21(5):594-603. PubMed ID: 659025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. II. Is the complement receptor necessarily present on the killer cells?
    Pross HF; Baines MG; Jondal M
    Int J Cancer; 1977 Sep; 20(3):353-8. PubMed ID: 903188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic cell features in lymphocytic leukemias: a review.
    Astaldi GC; Topuz U; Guarina L; Astaldi G
    Boll Ist Sieroter Milan; 1975 Jun; 54(2):108-19. PubMed ID: 54182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.
    Foa R; Lauria F; Lusso P; Giubellino MC; Fierro MT; Ferrando ML; Raspadori D; Matera L
    Br J Haematol; 1984 Nov; 58(3):509-16. PubMed ID: 6333890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulations.
    Gupta S; Fernandes G; Nair M; Good RA
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5137-41. PubMed ID: 311006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IV. The suppressive effect of normal pregnancy.
    Baines MG; Pross HF; Millar KG
    Am J Obstet Gynecol; 1978 Apr; 130(7):741-4. PubMed ID: 637095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
    Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
    J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte subpopulations in chronic lymphocytic leukemia (CLL). Relation to the activity of the disease.
    Mellstedt H; Pettersson D; Holm G
    Acta Med Scand; 1978; 204(6):485-9. PubMed ID: 367083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus.
    Charpentier B; Carnaud C; Bach JF
    J Clin Invest; 1979 Aug; 64(2):351-60. PubMed ID: 110833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural killer activity (cytotoxicity) of lymphocytes.
    Petrányi GG; Benczur M; Varga M; Györffy G; Gyódi E; Onody K; Hollán RS
    Ann Immunol Hung; 1979; 19():93-104. PubMed ID: 552228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell helper defect in patients with chronic lymphocytic leukemia.
    Chiorazzi N; Fu SM; Montazeri G; Kunkel HG; Rai K; Gee T
    J Immunol; 1979 Mar; 122(3):1087-90. PubMed ID: 376702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immune reactions in human acute leukemia.
    Herberman RB
    Hamatol Bluttransfus; 1974; 14():107-18. PubMed ID: 4615044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.